Monday
Dec132010
Roslin Cells Scoops the Mid and East Lothian Chamber of Commerce High Growth Award 2010
Edinburgh, UK, 13 December 2010 – On November 18 Roslin Cells Ltd. won the Midlothian and East Lothian Chamber of Commerce High Growth Award for 2010. The award, sponsored by the accountancy group Springfords, goes to businesses who demonstrate investment in future development that substantially improves their performance or potential growth.
The award recognises Roslin Cells’ strategic approach to the growth and development of its business which has been enabled through its continued success. Now operating with 23 staff and soon to expand to new custom GMP facilities at the Scottish Centre for Regenerative Medicine this award emphasises the positive impact Roslin Cells is having on the local life science community and the company’s intentions for further development to enhance its role within the wider regenerative medicine community.
Aidan Courtney, CEO, said: “We were delighted to receive the High Growth Award. Over the last few years Roslin Cells has established itself as one of the very few organisations in the world capable of creating new stem cell lines suitable for use in therapies. “It’s terrific to see this effort recognised. Through our new Cell Therapy Partner Programme we are establishing links with universities and life science companies Worldwide which will lead to new medical therapies being developed in the coming years which will drive our continued growth.”
Janet Downie, Operations Manager, said: “Receiving the High Growth Award has marked a real milestone for the team at Roslin Cells, having grown and developed significantly as a company particularly within the last year. We are fortunate to be situated in the Midlothian area as this has allowed us to employ talented and experienced staff, making this growth and development possible. We were really delighted to receive this award.”
About Roslin Cells
Roslin Cells Ltd was established in 2006 by the Roslin Institute with the support of the University of Edinburgh, the Scottish National Blood Transfusion Service and Scottish Enterprise. The company’s core mission is to provide ethically sourced, pluripotent human cells manufactured to the highest quality available according to Good Manufacturing Practice (GMP standards). This level of quality is critical to their intended use in therapeutic applications. By operating to such high standards, Roslin Cells is able to supply our partners and collaborators, premier quality pluripotent cell lines that are extensively characterised and tested. Our cell lines form the basic material with which our collaborators can develop cell therapies for clinical applications. They also represent the ideal starting material for researchers engaged in discovery research. Roslin Cells is headquartered in Roslin, Midlothian, and is a not for profit organisation.
For further information
Roslin Cells Ltd
Chief Executive Officer
Aidan Courtney
Tel +44 131 527 4243
Fax +44 131 527 4517
Monday, December 13, 2010 at 9:00AM 
